NewEdge Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
NewEdge Wealth's PFE Position: Q1 2026 in Review
NewEdge Wealth reduced its Pfizer (PFE) stake by 25% in Q1 2026, selling an estimated $706K and leaving 81,237 shares worth $2.28M. The position accounts for 0.03% of the portfolio, ranked #392.
NewEdge Wealth first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. The position peaked at $26.3M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- NewEdge Wealth held 81,237 shares of Pfizer worth $2.28M as of Q1 2026.
- NewEdge Wealth sold 26,519 Pfizer shares in Q1 2026, an estimated $706K.
- Pfizer made up 0.03% of NewEdge Wealth's portfolio in Q1 2026, its #392 holding.
- NewEdge Wealth first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
- NewEdge Wealth's Pfizer position peaked at $26.3M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.